tiprankstipranks
Trending News
More News >
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market

Xenetic Biosciences (XBIO) Income Statement

Compare
339 Followers

Xenetic Biosciences Income Statement

Last quarter (Q3 2025), Xenetic Biosciences's total revenue was $1.03M, an increase of 58.28% from the same quarter last year. In Q3, Xenetic Biosciences's net income was $-509.94K. See Xenetic Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.50M$ 2.54M$ 1.71M$ 1.16M$ 436.94K
Gross Profit
$ 2.50M$ 2.54M$ 1.71M$ 1.16M$ 436.94K
Operating Expenses
$ 6.70M$ 7.06M$ 8.42M$ 6.91M$ 14.37M
Depreciation and Amortization
$ 153.34K$ 0.00$ 27.04K$ 35.48K$ 28.84K
EBITDA
$ -4.05M$ -4.52M$ -6.69M$ -5.71M$ -4.67M
Operating Income
$ -4.20M$ -4.52M$ -6.72M$ -5.75M$ -13.94M
Other Income/Expenses
$ 244.15K$ 381.14K$ 165.56K$ 101.59K$ 125.68K
Pretax Income
$ -3.96M$ -4.13M$ -6.55M$ -5.65M$ -13.81M
Net Income
$ -3.96M$ -4.13M$ -6.55M$ -5.65M$ -10.89M
Per Share Metrics
Basic EPS
$ -2.57$ -2.71$ -4.49$ -5.39$ -17.04
Diluted EPS
$ -2.57$ -2.71$ -4.49$ -5.39$ -17.04
Weighted Average Shares Outstanding
1.54M 1.53M 1.42M 1.03M 639.24K
Weighted Average Shares Outstanding (Diluted)
1.54M 1.53M 1.42M 1.03M 639.24K
Currency in USD

Xenetic Biosciences Earnings and Revenue History